OUR
TECHNOLOGY
- OliPass PNA(OPNA)페이지 바로가기
-
OliPass Peptide Nucleic Acid (OliPass PNA) is derived from PNA by rationally introducing cationic lipid moiety onto nucleobase. By covalently attaching such cationic lipid groups onto PNA, the cell permeability markedly improved - thus a platform technology optimized for exon skipping inside the cell nucleus. OliPass Peptide Nucleic Acid (OliPass PNA) is derived from PNA by rationally introducing cationic lipid moiety onto nucleobase.
페이지 바로가기
- Exon Skipping페이지 바로가기
-
Since OliPass PNA (OPNA) specifically binds to the target region of the pre-mRNA to induce exon skipping, multiple new drug candidates can be discovered and it can be developed as a safe and efficacious therapeutic. Since OliPass PNA (OPNA) specifically binds to the target region of the pre-mRNA to induce exon skipping, multiple new drug candidates can be discovered and it can be developed as a safe and efficacious therapeutic.
페이지 바로가기